Psychopharmacologia

, Volume 44, Issue 3, pp 273–280

Clinical studies with dopamine-receptor stimulants

  • Burton Angrist
  • Hyacinth Thompson
  • Baron Shopsin
  • Samuel Gershon
Human Pharmacology

DOI: 10.1007/BF00428906

Cite this article as:
Angrist, B., Thompson, H., Shopsin, B. et al. Psychopharmacologia (1975) 44: 273. doi:10.1007/BF00428906

Abstract

Oral administration of ET-495 was found to cause worsening of psychiatric status in 4 out of 7 schizophrenic patients, and to induce a paranoid state and a syndrome of auditory hallucinosis in 2 non-schizophrenics. These observations were compatible with the hypothesized role of dopamine in schizophrenia. However, these psychotogenic effects were far less dramatic than those noted in other studies with amphetamine, methylphenidate or l-Dopa. Possible explanations for this differing psychotogenic potency of receptor stimulators versus presynaptic agonists are presented. Intravenous ET-495 and apomorphine did not show psychotogenic effects.

Key words

Schizophrenia Dopamine ET 495 Apomorphine Clinical studies 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • Burton Angrist
    • 1
  • Hyacinth Thompson
    • 1
  • Baron Shopsin
    • 1
  • Samuel Gershon
    • 1
  1. 1.Neuropsychopharmacology Research Unit, Department of PsychiatryNew York University Medical CenterNew York

Personalised recommendations